skinny.

Latest / Stock Movers

Sanofi Drops, Jet2 Warning, Burberry Rise

On this episode of Stock Movers:

- Sanofi’s experimental drug for the skin condition atopic dermatitis disappointed investors in a late stage trial, after the benefit of the drug was less than expected.

- Jet2 fell 25%. Trading volume was six times the average for this time of day. The stock reversed the previous session's gain.

- A year after losing its spot in Britain’s blue-chip benchmark, Burberry is returning to the UK’s stock-market elite. The luxury-goods maker, best known for its tartan-plaid trench coats, will rejoin the FTSE 100 Index later this month, index…

Log in to save or queue this episode.

The skinny

The skinny isn't ready yet — notes appear once the transcript is processed.